Home›Research›Compare›Ac-SDKP vs Cartalax
Peptide Comparison
Ac-SDKP vs Cartalax
Ac-SDKP
N-acetyl-seryl-aspartyl-lysyl-proline
No providers listed yet
Cartalax
Ala-Glu-Asp-Arg
Half-life: Unknown
4 providers listed
Quick Verdict
Ac-SDKP
Risk
Cartalax
Risk
Side-by-Side Comparison
About Ac-SDKP
Inhibits hematopoietic stem cell entry into S-phase. Blocks TGF-β1-mediated fibroblast activation, reducing collagen deposition. Promotes angiogenesis via VEGF upregulation. Regulated in vivo by ACE enzyme.
A naturally occurring tetrapeptide derived from thymosin beta-4 cleavage by prolyl oligopeptidase. Potent anti-fibrotic properties studied in cardiac, pulmonary, and renal fibrosis. Also promotes angiogenesis and wound healing.
Research Areas
About Cartalax
Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells
A Khavinson peptide bioregulator targeting cartilage tissue. Promotes chondrocyte activity and cartilage matrix regeneration; studied for osteoarthritis and joint degeneration.
Research Areas
Find Providers
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.